nzdusd

Signals

Sell NZDUSD (May 02, 2020)

NZDUSD Sell @ 0.6060 Profit @ 0.5960 Stop @ 0.6080 Rationale for selling NZDUSD Kiwi briefly rose amid the sharp...

Signals

Sell NZDUSD (May 04, 2020)

NZDUSD Sell @ 0.6040 Profit @ 0.5965 Stop @ 0.6065 Rationale for Selling NZDUSD: Prominent Dollar strength and the risk-off...

NZD/USD: Upside remains shallow

The NZD/USD pair seems like gaining slowly but the upside looks shallow as there is no strong follow-through momentum while...

News Feed

Oil Set for Best Week Since June With Saudis Defending Recovery

(Bloomberg) -- Oil is poised for its biggest weekly advance since early June with Saudi Arabia ratcheting up the pressure on OPEC+ members to adhere to the group’s production cuts amid signs demand is faltering.Futures in New York are up almost 11% this week, despite bearish calls on the outlook from industry heavyweights such as […]

Ericsson to buy wireless networking firm Cradlepoint in $1.1 bln deal

Ericsson has agreed to buy U.S.-based wireless networking company Cradlepoint in a $1.1 billion deal, the Swedish telecoms gear maker said on Friday. The deal, Ericsson's largest in more than a decade, would give it access to tools that can connect devices using the so-called Internet of Things over a 4G or a 5G network. […]

Gold gains as softer dollar, economic concerns bolster appeal

Spot gold climbed 0.6% to $1,953.70 per ounce by 0710 GMT, up 0.6% so far this week. U.S. gold futures were 0.6% higher at $1,961.30. The dollar index was on track for a weekly fall, making gold more attractive for those holding other currencies.

Kinross Gold Pays First Dividend in 7 Years With Metal Rallying

(Bloomberg) -- Canadian miner Kinross Gold Corp. is boosting output and paying its first dividend in seven years after gold prices surged to a record.The Toronto-based company will give shareholders 3 cents a common share, and resume quarterly dividends of the same amount, taking the total distribution to 12 cents a year, according to a […]

Arrowhead Hits the Bullseye in Phase 2 Study of ARO-AAT; Analyst Targets Over 90% Upside

Wednesday was a good day for investors of biotech Arrowhead Pharmaceuticals (ARWR). Shares took off to the tune of 40% following the release of positive trial data.In the Phase 2 open-label trial (AROAAT2002) assessing ARO-AAT for the rare genetic liver disease associated with alpha one antitrypsin deficiency (AATD), the treatment displayed convincing proof of a […]

Sell NZDUSD (May 02, 2020)

Sell NZDUSD (May 04, 2020)

NZD/USD: Upside remains shallow

Bruce Kovner Forex Strategy

Weekly Forex Analysis (July 13 – 17)

Why can the Dollar be left without the support of China?

Weekly forex analysis: 6 – 10 July, 2020

Our Company

Navigate our site

Be a BlackPipper

You may have missed